Originator Organization Biomunex Pharmaceuticals SASStartup |
Active Organization Biomunex Pharmaceuticals SASStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | FR | Biomunex Pharmaceuticals SASStartup | 07 Apr 2022 |